Drug Search Results
More Filters [+]

Dexpramipexole

Alternative Names: dexpramipexole, kns-760704, kns760704, kns 760704
Latest Update: 2024-08-29
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Knopp Biosciences
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Dexpramipexole

Countries in Clinic: Argentina, Austria, Brazil, Bulgaria, Canada, Colombia, Czech Republic, Georgia, Germany, Hungary, Italy, Korea, Lithuania, Macedonia, Mexico, Poland, Romania, Serbia, South Africa, South Korea, Spain, United Kingdom, United States

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Asthma|Pulmonary Eosinophilia

Phase 2: Chronic Obstructive Pulmonary Disease

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

EXHALE-5

P3

Enrolling by invitation

Pulmonary Eosinophilia|Asthma

2027-06-01

jRCT2031240072

P3

Not yet recruiting

Asthma

2026-12-11

EXHALE-2

P3

Recruiting

Asthma|Pulmonary Eosinophilia

2026-06-01

EXHALE-3

P3

Recruiting

Pulmonary Eosinophilia|Asthma

2026-06-01

Recent News Events